ストックスクリーナーアプリを入手
2.44
0.62%
0.015
アフターアワーズ：
2.48
0.04
+1.64%
前日終値:
$2.425
開ける：
$2.4
24時間の取引高:
16,839
Relative Volume:
0.28
時価総額：
$7.37M
収益：
$4.88M
当期純損益:
$-3.66M
株価収益率:
-1.5901
EPS:
-1.5345
ネットキャッシュフロー:
$-2.80M
1週間 パフォーマンス:
-4.50%
1か月 パフォーマンス:
-9.63%
6か月 パフォーマンス:
-37.60%
1年 パフォーマンス:
-52.34%
1日の値動き範囲:
$2.38
$2.46
1週間の範囲:
$2.38
$2.62
52週間の値動き範囲:
$2.11
$8.80
Biomerica Inc Stock (BMRA) Company Profile
BMRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
2.44 | 7.32M | 4.88M | -3.66M | -2.80M | -1.5345 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-11-10 | 開始されました | Colliers Securities | Buy |
| 2018-01-04 | 開始されました | B. Riley FBR, Inc. | Buy |
Biomerica Inc (BMRA) 最新ニュース
Trend Recap: Is Biomerica Inc being accumulated by smart moneyQuarterly Profit Summary & Smart Swing Trading Alerts - baoquankhu1.vn
Short Covering: What is the next catalyst for Biomerica IncDip Buying & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Should value investors consider Biomerica Inc2025 Trading Volume Trends & Free Verified High Yield Trade Plans - baoquankhu1.vn
Short Covering: Is Biomerica Inc stock risky to hold nowWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Macro Review: Is Biomerica Inc backed by strong institutional buying2025 Breakouts & Breakdowns & Technical Pattern Alert System - baoquankhu1.vn
US-based Biomerica reports net sales of USD 1.21M in Q2 2026 - Medical Buyer
Medical diagnostics firm Biomerica's Q2 revenue falls amid product transition - TradingView — Track All Markets
BIOMERICA INC SEC 10-Q Report - TradingView
Medicare sets $300 price for IBS test as Biomerica expands AI diet tool - Stock Titan
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Expands By 123.2% - Defense World
Bullfrog AI Holdings, Inc. (NASDAQ:BFRGW) Short Interest Update - Defense World
Earnings Miss: Is Biomerica Inc stock risky to hold nowPortfolio Update Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
How interest rate cuts could boost Biomerica Inc. stockPortfolio Value Summary & Free Verified High Yield Trade Plans - Улправда
Will Biomerica Inc. stock maintain dividend yield2025 Key Highlights & Expert Approved Momentum Ideas - Улправда
Is Biomerica Inc. stock safe for conservative investorsBuy Signal & Reliable Breakout Forecasts - Улправда
Can Captivision Inc. stock deliver strong Q4 earningsTreasury Yields & Daily Entry Point Trade Alerts - Улправда
How Biomerica Inc. stock responds to policy changesInsider Selling & Weekly Setup with ROI Potential - Улправда
How supply chain issues affect Rain Enhancement Technologies Holdco Inc. Equity Warrant stockQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - Улправда
Why CRVS stock is rated strong buyWeekly Gains Summary & Fast Moving Market Watchlists - Улправда
Will Bulten AB (publ) (3FB) stock return to pre crash levels2025 Dividend Review & Technical Entry and Exit Tips - Улправда
Targets Report: Why Adams Natural Resources Fund Inc. stock remains stableWeekly Investment Recap & Risk Controlled Stock Alerts - Улправда
Is The Vita Coco Company Inc. stock trading at a premium valuationIPO Watch & Safe Capital Growth Plans - Улправда
Zodiac Energy Limited (ZODIAC) Signs Major DealGap Up/Gap Down Analysis & Budget Friendly Trading Strategies - bollywoodhelpline.com
Biomerica Adds Most New Retail Followers Among Biotechs After UAE Nod For Prostate Cancer Screening Test - MSN
Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World
Biomerica (BMRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
Biomerica stock soars after Medicare sets $300 payment rate for IBS test - Investing.com Australia
Medicare to pay $300 for Biomerica’s IBS test starting January 2026 - Investing.com Nigeria
Biomerica Gains Exposure as Distribution Expands in Egypt - StocksToTrade
Biomerica’s Market Presence Expands with Egyptian Drug Authority Authorization - timothysykes.com
Biomerica stock soars after Medicare sets $300 payment rate for IBS test By Investing.com - Investing.com Nigeria
Medicare to pay $300 for Biomerica’s IBS test starting January 2026 By Investing.com - Investing.com South Africa
Biomerica, Inc. Announces Medicare Payment Rate for inFoods® IBS Test Set at $300 Effective January 1, 2026 - Quiver Quantitative
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test - The Manila Times
Biomerica announces CMS Medicare payment rate of $300 for revolutionary Infoods® IBS test - marketscreener.com
Medicare sets $300 price for new food-trigger test to ease IBS pain - Stock Titan
Why Biomerica Inc. stock remains a top recommendationJuly 2025 Analyst Calls & Verified Technical Trade Signals - Улправда
Biomerica stockholders approve key proposals at annual meeting - MSN
Will Biomerica Inc. stock attract more institutional investorsTrade Signal Summary & Expert Verified Movement Alerts - Улправда
Market Review: Is Biomerica Inc. stock a safe haven assetMarket Activity Recap & Scalable Portfolio Growth Methods - Улправда
Will Biomerica Inc. stock recover faster than marketWeekly Market Report & Consistent Income Trade Ideas - Улправда
Can Biomerica Inc. stock maintain operating marginsTrade Volume Report & Stock Portfolio Risk Management - Улправда
What makes Biomerica Inc. stock attractive to growth fundsSmall Cap Stock Opportunities & Minimal Capital Investment - ulpravda.ru
Is Biomerica Inc. stock a safe haven assetJuly 2025 PostEarnings & AI Enhanced Market Trend Forecasts - Улправда
Biomerica Earnings Notes - Trefis
Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average – What’s Next? - Defense World
Biomerica Stockholders Approve Key Proposals at Annual Meeting - TipRanks
Egyptian drug authority approves Biomerica’s cancer screening portfolio By Investing.com - Investing.com Australia
Biomerica (BMRA) Gains Approval for Rapid Tests in Egypt - GuruFocus
Egyptian drug authority approves Biomerica’s cancer screening portfolio - Investing.com
Biomerica Inc (BMRA) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
0.96%
大文字化:
|
ボリューム (24 時間):